Project Grant R21CA292195
Award Date
4/11/25
Completion Date
3/31/27
Dollars Obligated
$227K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Washington, DC, USA
Similar Awards
This is a Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $1,218,738.00 to study tobacco use disparities among sexual minority young adults (SMYA) in rural versus urban areas. The research project aims to elucidate the impact of minority stress factors, such as mental health problems, family stress, lack of peer support, and discrimination, on tobacco use patterns and escalations among SMYA across...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the relative risks of tobacco products. The project aims to generate effective messaging on the continuum of tobacco product risks, assess their impact on message response, receptivity, and behavioral precursors,...
This $957,600 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports a multi-component research project led by Drexel University to develop a framework for community-directed tobacco harm reduction approaches. The key objectives are to: Identify multilevel drivers of tobacco use among Black and Latinx adult sexual and gender minorities using a community-driven systems modeling process. Evaluate...
This Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support research to characterize dual marijuana and tobacco use in young adults. The $594,099 award to Brown University will utilize novel behavioral economic measures to examine the behavioral mechanisms underlying marijuana and tobacco co-use in this high-risk population. Specifically, the research will employ a cross-price elasticity of demand task...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, provides $129,708 to Purdue University to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use. The key objectives are to: 1) Analyze the effect of tobacco retailer licensing laws and fees on differences in retailer density by race/ethnicity, income, and education; 2) Measure the impact of flavored tobacco product...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $188,913 to Virginia Commonwealth University (VCU) to conduct research on nicotine continuum of risk education for socioeconomically disadvantaged adult smokers. The key objectives are to: 1) assess perceptions of the continuum of risk among low-socioeconomic status (low-SES) smokers using...
The National Cancer Institute (NCI) awarded a $1,319,898 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The General Hospital Corporation, doing business as Massachusetts General Hospital, to adapt and test a smoking cessation intervention tailored for transgender and gender-diverse (TGD) individuals. The project aims to explore how gender minority stressors and associated anxiety/depression compromise smoking cessation in this population, adapt an...
The National Institutes of Health (NIH) Office of the Director awarded a $675,599 project grant under the Trans-NIH Research Support program (CFDA 93.310) to Rutgers, The State University of New Jersey. This 1-year grant, running from September 1, 2024 to August 31, 2025, will fund a study to characterize the implementation, reach, and impact of court-ordered tobacco corrective statement postings at retail point-of-sale locations across the United States. The study aims to: 1) assess...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will fund a three-year, $515,632 research project to estimate the impact of potential U.S. Food and Drug Administration (FDA) cigarette product standards on smoking cessation rates in each U.S. state. The key objectives are to: 1) Estimate the number of people who smoke, including priority populations, who will quit smoking and enroll in state quitlines in...
This is a Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research federal grant program (CFDA 93.393). The $619,175 award will support a clinical trial to evaluate the effectiveness of an e-cigarette switching approach as a harm reduction intervention for oncology outpatients who smoke but refuse traditional tobacco treatment. The trial, conducted by the Medical University of South Carolina, will directly compare rates of switching to...